forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Agonists Weight Loss Drugs

[DOI] [PubMed] [Google Scholar] Igamberdiev AU, Bykova NV, Hill RD

Dubois-Deruy E, Peugnet V, Turkieh A, Pinet F

The global obesity GLP-1 market size accounted for USD 8.21 billion in 2025 and is predicted to increase from USD 10.12 billion in 2026 to approximately USD 66.57 billion by 2035, expanding at a CAGR of 23.28% from 2026 to 2035

bmiMD does not manufacture compounded medications, and product appearance may differ from website images

Following oral administration of Bay 27-9955 at two doses, a significant blunting of acute hyperglycaemia was observed following a glucagon infusion, in the absence of clinical side effects

At Total Anti-Aging and Wellness, they understand how big of a deal this is